Merry Christmas Eve to all who celebrate Christmas, and Happy Holidaze to everyone! Just a heads up—this week’s link roundup is going to come out sometime next week instead. I bit off more than I could chew this week and wasn’t able to finish it, and I’ll need to work on it over the weekend to get it ready for publication. Thanks for your patience and I’ll see you next week!
This Week in Psychedelics - 12.17.21
Cannabis
Malta becomes first EU country to legalise cannabis for personal use (Euronews)
St. Louis Mayor Signs Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)
No Fentanyl Found in Cannabis After All, Vermont Police Say (High Times)
Viral story shared across social media about two teens overdosing on fentanyl-laced marijuana in Springfield was untrue (MassLive)
Ministry pushes full cannabis legalisation (Bangkok Post)
Government-Funded Study Shows Unprecedented Decline in Marijuana Use By Young People (NORML)
Pfizer to Acquire Pharmaceutical Company Testing Cannabinoid Treatment (High Times)
Heavy metals in cannabis plants could affect human health, study finds (New Atlas)
Rhode Island Legalization Bill Set for Early 2022 Introduction (High Times)
Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees (NORML)
Smoking CBD-Rich Marijuana Has ‘No Significant Impact’ On Driving Ability, Study Finds (Marijuana Moment)
Cannabis use could cause harmful drug interactions (ScienceDaily)
LSD
Cary Grant Is High on LSD in ‘Flying Over Sunset.’ Everyone Else Has a Bad Trip. (The Daily Beast)
PharmaTher Announces Positive Research Results for LSD Microneedle Patch (BioSpace)
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD (Psilocybin Alpha)
Magic Mushrooms
New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin (VICE)
Psilocybin-assisted psychotherapy reduces loss of meaning and suicidal ideation among cancer patients (PsyPost)
With health care workers hurting, a doctor wants to see if a psychedelic can help (NBC News)
COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study (Psilocybin Alpha)
More patients granted psilocybin exemption by federal government (CBC)
Warning: Oregon Legalized Supported Adult Use of Psilocybin, Not Psychedelic Therapy (Chacruna)
New York Lawmaker Files Bill To Legalize Medical Psilocybin Treatments, With Focus On First Responders And Veterans (Marijuana Moment)
This Trippy New Book Takes You Through Modern Mushroom History—With Cartoons (DoubleBlind)
Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA (Psilocybin Alpha)
Silo Wellness announces series of psilocybin retreats in Jamaica (Globetrender)
HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes (Psilocybin Alpha)
MDMA
The Big Return – and Decline in Quality – of MDMA (VICE)
Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD (The Conversation)
MDMA could soon be used to treat PTSD according to physicians (Mixmag)
Ayahuasca
Study links the ceremonial use of ayahuasca to robust reductions in neuroticism (PsyPost)
Educating Gringos in Shipibo Ways (Chacruna)
Esther Jean Langdon: Half a Century of Research About Shamanism and Ayahuasca (Chacruna)
Novel Psychoactive Substances
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders (Psilocybin Alpha)
atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)
Synthetic Cannabinoids
Tainted synthetic marijuana linked to severe bleeding cases in Florida (Live Science)
Miscellaneous
Psychedelics Rejected for Therapeutic Use in Australia (VICE)
Can a Values-Centered Psychedelic Ecosystem Effectively Compete? (Lucid News)
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy. (Mind Medicine Australia)
How Do Psychedelics Change Your Personality? These Researchers Tried To Find Out (IFLScience)
‘This isn’t the 60s again’: psychedelics business takes off amid culture clash (The Guardian)
2022 Global Drug Survey: Help make it bigger than ever for its 10 year anniversary (TalkingDrugs)
Most Addiction Specialists Support Legalized Therapeutic Psychedelics (Medscape)
Psychedelic-Assisted Therapy on the Rise in VA Hospitals (Lucid News)
Psychedelics and Substance Use Disorder: 4000 BCE to Present Day (Psychedelic Science Review)
Many Indians Are Experimenting With Psychedelics, Other Drugs to Deal With Mental Health Issues (The Swaddle)
Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity (Psychedelic Science Review)
atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics (Psilocybin Alpha)
How to Start Microdosing Psychedelics (DoubleBlind)
Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk (Psychedelic Spotlight)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.
This Week in Psychedelics - 12.10.21
Cannabis
New Study Determines Correlation Between Cannabis and Sleep (High Times)
Marijuana banking legislation stripped from federal defense spending bill (Marijuana Business Daily)
San Francisco delays cannabis tax so that dispensaries can compete with illegal dealers (Boing Boing)
Costa Rica’s Constitutional Court Approves Cannabis Legalization Bill (High Times)
World’s largest THC-infused brownie weighs in at 850 pounds (Leafly)
CBD Products Commonly Flagged by FDA for Making Unsubstantiated Claims About Treating COVID-19 (NORML)
Luxembourg Publishes Details on Domestic Recreational Cannabis Plan (High Times)
Montana Lawmakers Reject Marijuana Rules, Weeks Ahead Of Legal Sales Launch (Marijuana Moment)
Allowing Legal Marijuana Dispensaries Boosts Employment Rates In Colorado Counties, Study Finds (Marijuana Moment)
Missouri Police Couldn’t Use Marijuana Odor To Justify Searches Under New Bill (Marijuana Moment)
Ohio GOP Lawmakers File New Marijuana Legalization Bill (Marijuana Moment)
Indiana GOP Lawmaker Plans Medical Marijuana Bill As Democrats Push Full Recreational Legalization (Marijuana Moment)
Virginia Lawmakers Tout Benefits Of Psychedelics As Activists Prepare Push For Statewide Reform (Marijuana Moment)
Producing Cannabis Biomass Without Growing A Cannabis Plant: How One Company Is Doing It (Forbes)
Hemp Sourced Lignin for Grid Backup Batteries (Drug WarRant)
Magic Mushrooms
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression (Psilocybin Alpha)
Psilocybe allenii: The Bay Area Shroom No One Can Recognize (DoubleBlind)
Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting (Psilocybin Alpha)
Psirenity Announces Exclusive Licence Agreement for Psilocybin (PR Newswire)
MDMA
Did the Cult From 'Wild Wild Country' Introduce MDMA to Ibiza? (VICE)
Can MDMA Increase Women’s Sexual Desire? (DoubleBlind)
DMT
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2 (Yahoo!)
Ayahuasca
Instagram decision to remove ayahuasca post overturned by Meta Oversight Board (The Verge)
Chacruna Institute Publishes New Book on Ayahuasca Healing and Science (Chacruna)
Peyote
The Ancient Tradition Of The Peyote Ceremony (Benzinga)
Iboga
U.S. Government Will Test Ibogaine Derivative As An Addiction Treatment (Forbes)
Novel Psychoactive Substances
BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression (GlobeNewswire)
Psilera Confirms PSIL-002, A New DMT Derivative, is Well-Tolerated and Non-Hallucinogenic from In Vivo Behavioral Studies (Psilocybin Alpha)
Ketamine
Evidence Inconclusive for Ketamine as Bipolar Depression Treatment (Psychiatry Advisor)
Miscellaneous
Middle-class drug users could lose UK passports under Boris Johnson’s plans (The Guardian)
Toronto Asks Feds to Decriminalize All Drugs (Truffle Report)
United Nations Panel Rejects International Kratom Ban (Marijuana Moment)
New Zealand to ban smoking for next generation in bid to outlaw habit by 2025 (The Guardian)
The Future is Research: UK Government Publishes 10-Year Drug Strategy - Drug Science Responds (Drug Science)
Horizons 2021: Creating the future of psychedelics (The Psychedelic Renaissance)
Report finds Instagram makes it easy for teens to find drugs online (Engadget)
‘Magic' Mushrooms, Ecstasy, Other Psychedelics Could Become Legal in California (NBC San Diego)
The Wild World of 19th Century Psychedelics (Psychedelics Today)
People Changed the Ways They Use Drugs During the Pandemic (Filter)
You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study Shows (Psychedelic Spotlight)
Study suggests psychedelics promote positive mental health through increased spirituality and emotion regulation (PsyPost)
Editor’s Choice Award 2021-Best Study on Psychedelics and Pharmacology (Psychedelic Science Review)
40 under 40 Outstanding BIPOC leaders in Drug Policy (DoubleBlind)
Taking Microdosing with a Pinch of Salt (Lucid News)
Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders (Yahoo!)
Nue Life announces donations to Multidisciplinary Association for Psychedelic Studies and Ketamine Research Foundation (PR Newswire)
Editor’s Choice Award 2021-Best Study on Psychedelics and Nature (Psychedelic Science Review)
atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual property portfolio and strengthen atai’s supply chain (Psilocybin Alpha)
Shaman Claus: The Shamanic Christmas Origins (Reality Sandwich)
Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer's License Application (Yahoo!)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.
This Week in Psychedelics - 12.3.21
Cannabis
Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)
Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)
Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)
South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)
Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)
Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)
Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)
California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)
Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)
Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)
Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)
Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)
Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)
Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)
LSD
Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)
How LSD changed The Beatles forever (Far Out Magazine)
Magic Mushrooms
New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)
U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)
Ayahuasca
Sexual Assault in the Amazon (The Cut)
Iboga
Ibogaine and Cardiac Arrhythmia: The Heart of the Matter (Psychedelic Science Review)
Novel Psychoactive Substances
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)
Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)
Nitrous Oxide
‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)
Dozens of traffic accident deaths linked to laughing gas use (NL Times)
Ketamine
Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)
As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)
Miscellaneous
New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)
Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)
Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)
Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)
DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)
People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)
Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)
Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)
The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)
Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)
Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)
Will the psychedelic revolution bypass people of color? (The Lens)
Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)
Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)
Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)
Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)
Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)
Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)
Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)
Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)
Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.
This Week in Psychedelics - 11.26.21
Cannabis
The new German government plans to legalize cannabis. (The New York Times)
Mexico Senate on Track to Endorse Recreational Cannabis by December (High Times)
Uber Eats users in Ontario can now buy cannabis through the app (Engadget)
New GOP weed approach: Feds must ‘get out of the way’ (Politico)
South Dakota Supreme Court kills adult-use legalization (Leafly)
Is Fentanyl-Tainted Marijuana 'Something Real' or 'Just an Urban Legend'? (Reason)
A New Center at CSU Aims to Unlock the Secrets of CBD (5280)
Indica and sativa labels are largely meaningless when it comes to cannabis complexities (The Conversation)
St. Louis Lawmakers Unanimously Approve Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)
Analysis: Marijuana Legalization Associated with Improved Clearance Rates for Violent Crimes (NORML)
Illinois Judge Rules Weed Odor is Not Probable Cause For Searches (High Times)
Ohio Marijuana Activists Almost Have Enough Signatures To Force Lawmakers To Consider Legalization (Marijuana Moment)
New Mexico Issues First Adult-Use Cannabis Cultivation License (High Times)
Taliban Contracts Australian Company To Grow Cannabis In Afghanistan (Marijuana Moment)
Mississippi lawmakers unlikely to reach medical marijuana deal this year (Marijuana Business Daily)
Dogs Are Being Exposed To Marijuana Through Human Poop And Pet Owners Should Beware, Study Finds (Marijuana Moment)
Majority Of Texas Republicans Back Marijuana Legalization, Poll Finds (Marijuana Moment)
Arizona Cannabis Social Equity Program Faces Legal Challenge (High Times)
Canada’s first regulated cannabis suppositories target female consumers (Marijuana Business Daily)
Montana: Officials Create New Drug Court to Focus Solely on Expunging Past Marijuana Convictions (NORML)
Few Medical Cannabis Licenses in Portugal Have Been Awarded (High Times)
Pennsylvania order targeting vaporized products upends cannabis market (Marijuana Business Daily)
CNN’s Sixth WEED Documentary Features the Benefits of Medical Cannabis for Autism (High Times)
LSD
New graphic novel depicts famed history of LSD research in Sask. (CBC)
Magic Mushrooms
Magic mushroom study hints psilocybin repairs alcohol-induced brain damage (Inverse)
COMPASS Pathways granted fifth US patent for crystalline psilocybin (Psilocybin Alpha)
Metaphysics and mushrooms: Psychedelics can change how you think about the universe (Big Think)
What Happens When Zen Monks Take Mushrooms? (Lucid News)
HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada (Psilocybin Alpha)
MDMA
Police Presence at Music Festivals Linked to "Panic Overdoses": Study (EDM)
DMT
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs (Psilocybin Alpha)
Ayahuasca
Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony (PsyPost)
Are All Ayahuasca Retreats The Same? You Might Be Surprised (Healing Maps)
Peyote
Mining and Poaching Threatens 15,000-Year-Old Peyote Tradition in Mexico (DoubleBlind)
San Pedro
San Pedro: What is it Like to Experience Mescaline from San Pedro? (The Third Wave)
Novel Psychoactive Substances
Mescaline-Like Psychedelic Alters Synaptic Plasticity (Technology Networks)
Ketamine
Ketamine benefits neurocognition in depression with suicidal ideation (Healio)
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments (Psilocybin Alpha)
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus (Psilocybin Alpha)
Navigating the Patchwork of New York City Ketamine Clinics (Lucid News)
Miscellaneous
New Zealand Permanently Legalizes Drug Checking, a Global First (Filter)
U.S. Reports More Than 100,000 Overdose Deaths In One Year (High Times)
New study finds 'microdosing' psychedelics can be effective in treating anxiety, depression (The Hill)
Responding to the 2022 Global Drug Survey Will Help Other Drug Users (Filter)
Colorado Springs Pushing to Decriminalize Psychedelics (Truffle Report)
The Rise of Psychedelic Retreats (The New York Times)
How to Cultivate a More Ethical, Inclusive Psychedelic Future (Lucid News)
Why Are Some People More Sensitive to Psychedelics Than Others? (Sam Woolfe)
Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities (Psilocybin Alpha)
Academic Centers Start to Take Psychedelics Seriously (Medpage Today)
Psychedelics and Mysticism: The Debate Continues (Psychedelic Science Review)
Psychedelics, Cognition, and Sleep Disorders (Truffle Report)
Is Psychedelic Research Funding Starting to Shift? (Medpage Today)
Revive Therapeutics Files for ODD Designation for Bucillamine Treatment Targeting Rare Liver Disorders, COVID-19 (Truffle Report)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.